Kimberly Sue Mcallister-thomas, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1184 Sb Road, Mitchell, NE 69357 Phone: 308-631-3860 |
News Archive
NanoLogix, Inc. announces that the company has recently filed BNP™ (BioNanoPore) national patent applications in China, Japan, India, Brazil, Russia and the EU. These applications were filed in order to obtain intellectual property protection for the company's technology in countries viewed as representing the largest potential international market for BNP rapid detection, a revolutionary sandwiched-membrane Petri-based technology that can reduce microorganism detection times by 100-400%.
I'd never [before] been encouraged to sit at a patient's bedside -; to stop hurrying for even a moment. Our medical teachers put a premium on accuracy and efficiency, which became conflated with speed.
News outlets are considering the next moves for Texas' Women's Health Program after the federal government said it won't renew its funding for the program over the state's plan to cut off funding for Planned Parenthood. In the meantime, state legislatures in Colorado, Mississippi, New Hampshire and Pennsylvania consider contraception and abortion legislation.
Rheumatologists at the Annual European Congress of Rheumatology in Vienna, Austria heard today (Thursday 9 June) that rituximab is the first drug in a quarter of a century that is making a real impact, and an alternative to previous standard treatments of high-dose steroids, and chemotherapy.
Throughout our lives we are exposed to an enormous range of man-made chemicals, from food, water, medicines, cosmetics, clothes, shoes and the air we breathe. At the request of the EU, researchers at the University of Gothenburg, Sweden, have looked at the risk of "chemical cocktails" and have proposed a number of measures that need to be implemented in the current practice of chemical risk assessment.
› Verified 8 days ago